Wound care is a major challenge to the public health, and the burden is rapidly growing due to increasing health care costs, an aging population and a sharp rise in the incidence of disease such as diabetes and obesity that contribute to poor wound healing. While multiple factors may contribute to complications associated with wound healing, compromised tissue repair represents an underlying cause for non-healing wounds. A recent series of studies by the investigator?s team identified a novel TRIM family protein named MG53 as an essential component of the cell membrane repair machinery. Here we provide evidence that MG53 is a vital component of wound healing and that topical application of recombinant human (rh)MG53 protein has potential to promote healing of chronic wounds. MG53 is capable of nucleating the membrane repair machinery in keratinocytes, therefore protecting injuries to the epidermis. MG53 present in the extracellular solution can facilitate migration of fibroblasts in response to scratch wounding, thus contributing to efficient reepithelization of wound closure. Moreover, we made a novel finding that links circulating MG53 to the engagement of epithelial stem cells during the chronic and remodeling phase of wound closure. While epithelial stem cells do not express endogenous MG53 protein, they can take up MG53 from circulation in response to dermal injury. Therapeutic efficacy of rhMG53 will depend on the formulation as well as the approaches of delivering MG53. Direct administration of MG53 to the wound site and indirect delivery by intravascular injection are possible approaches, but will have low efficacy due to the short half-life of MG53 in blood circulation. It is important that we develop a proper formulation for sustained delivery of rhMG53 to the wound site in order to enhance therapeutic efficacy. The goal of this project is to test the hypothesis that MG53 facilitates healing of chronic wounds by enhancing cell membrane repair and epithelial stem cell function, and hydrogel formulation of rhMG53 represents an effective means for dermal wound healing.
Three specific aims are proposed: a) elucidate the mechanisms that underlie MG53?s function in wound healing (Aim 1); b) develop hydrogel-based delivery of rhMG53 to treat dermal wound (Aim 2); and c) conduct proof-of-concept study on rhMG53/hydrogel for chronic wound healing application (Aim 3). Fulfillment of these studies should advance our knowledge on the biology of MG53 in wound healing and lay the foundation for translational application of rhMG53 in treating chronic wounds in the elderly population.

Public Health Relevance

Development of a therapeutic approach to facilitate healing of chronic wounds represents an important area of biomedical and clinical research and will benefit the nursing care of the elderly. We aim to investigate the biological base of MG53 in wound healing and to develop a hydrogel formulation of MG53 protein in wound care.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG056919-02
Application #
9548547
Study Section
Bioengineering, Technology and Surgical Sciences Study Section (BTSS)
Program Officer
Williams, John
Project Start
2017-09-01
Project End
2022-05-31
Budget Start
2018-07-15
Budget End
2019-05-31
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Ohio State University
Department
Surgery
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Ogunbayo, Oluseye A; Duan, Jingxian; Xiong, Jian et al. (2018) mTORC1 controls lysosomal Ca2+ release through the two-pore channel TPC2. Sci Signal 11:
Fan, Zhaobo; Xu, Zhaobin; Niu, Hong et al. (2018) An Injectable Oxygen Release System to Augment Cell Survival and Promote Cardiac Repair Following Myocardial Infarction. Sci Rep 8:1371
Zhu, Qingxia; Li, Xiaofei; Fan, Zhaobo et al. (2018) Biomimetic polyurethane/TiO2 nanocomposite scaffolds capable of promoting biomineralization and mesenchymal stem cell proliferation. Mater Sci Eng C Mater Biol Appl 85:79-87
Fan, Zhaobo; Fu, Minghuan; Xu, Zhaobin et al. (2017) Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction. Biomacromolecules 18:2820-2829
Li, Mi; Li, Haichang; Li, Xiangguang et al. (2017) A Bioinspired Alginate-Gum Arabic Hydrogel with Micro-/Nanoscale Structures for Controlled Drug Release in Chronic Wound Healing. ACS Appl Mater Interfaces 9:22160-22175
Lin, Pei-Hui; Sermersheim, Matthew; Li, Haichang et al. (2017) Zinc in Wound Healing Modulation. Nutrients 10:
Li, Chuan; Matsushita, Satoshi; Li, Zhengqing et al. (2017) c-kit Positive Cardiac Outgrowth Cells Demonstrate Better Ability for Cardiac Recovery Against Ischemic Myopathy. J Stem Cell Res Ther 7:
Chen, Ken; Xu, Zaicheng; Liu, Yukai et al. (2017) Irisin protects mitochondria function during pulmonary ischemia/reperfusion injury. Sci Transl Med 9:
Yue, Tao; Park, Ki Ho; Reese, Benjamin E et al. (2016) Quantifying Drug-Induced Nanomechanics and Mechanical Effects to Single Cardiomyocytes for Optimal Drug Administration To Minimize Cardiotoxicity. Langmuir 32:1909-19
Xu, Yanyi; Patnaik, Sourav; Guo, Xiaolei et al. (2014) Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix. Acta Biomater 10:3449-62